(19)
(11) EP 0 929 568 A2

(12)

(43) Date of publication:
21.07.1999 Bulletin 1999/29

(21) Application number: 97939105.0

(22) Date of filing: 10.09.1997
(51) International Patent Classification (IPC): 
C12N 15/ 02( . )
A61K 38/ 06( . )
A61K 39/ 395( . )
A61P 25/ 00( . )
A61P 33/ 06( . )
A61P 37/ 06( . )
C07K 5/ 08( . )
C07K 7/ 06( . )
C07K 14/ 155( . )
C07K 14/ 54( . )
C07K 16/ 18( . )
C07K 16/ 44( . )
A61K 39/ 00( . )
A61K 38/ 00( . )
A61K 38/ 20( . )
A61P 17/ 00( . )
A61P 31/ 04( . )
A61P 37/ 04( . )
A61P 43/ 00( . )
C07K 5/ 10( . )
C07K 7/ 08( . )
C07K 14/ 16( . )
C07K 16/ 10( . )
C07K 16/ 24( . )
C12P 21/ 08( . )
(86) International application number:
PCT/IB1997/001086
(87) International publication number:
WO 1998/010787 (19.03.1998 Gazette 1998/11)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 11.09.1996 US 19960025180P

(71) Applicant: Prendergast, Patrick Thomas
Straffan Kildare (IE)

(72) Inventor:
  • Prendergast, Patrick Thomas
    Straffan Kildare (IE)

(74) Representative: Pidgeon, Robert John 
Appleyard Lees 15 Clare Road
Halifax West Yorkshire HX1 2HY
Halifax West Yorkshire HX1 2HY (GB)

   


(54) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF IMMUNE DISORDERS